JAGUAR HEALTH, INC. Adjustment of Warrants Granted for Services
JAGUAR HEALTH, INC. (JAGX) reported Adjustment of Warrants Granted for Services of $1.90 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2022-03-11
- JAGUAR HEALTH, INC. adjustment of warrants granted for services for fiscal 2020 was $1.90M.
| Period end | Adjustment of Warrants Granted for Services 12 month |
|---|---|
| 2020-12-31 | $1.90M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |